Work

A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults

Year: 2016

Type: article

Source: ORBi (University of Liège)

Authors: Thomas Werfel, Victoria Lynch, Aliya Asher, Athanasios Tsianakas, Bhanu Gupta, R. Sarmiento, Anna Płoszczuk, Bernadetta Majorek‐Olechowska, B. Cimoszko, Arjen Nikkels, T Hofman, Petra Staubach, Kristine Breuer, Alexander Gawlik, Krzysztof Buczyłko, M. Morren, Gary Layton, M. Yeadon, Lyndsey A. Whitlock, Lynn Purkins, W. Liu

Institutions: Medizinische Hochschule Hannover, MAC Clinical Research (United Kingdom), University of Münster, Centre Hospitalier Universitaire de Liège

Language: German

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2953487496

FWCI: 4.669

Cites:

Cited by: 15

Related to: 10